“…Notably, our results showed that CD47 expression decreased after GSK-3β inhibition. The roles of GSK-3β in cardiac biology are well recognized ( Beurel et al, 2015 ; Lal et al, 2015 ; Zhou et al, 2016 ; Sharma et al, 2020 ). GSK-3β is involved in the development of many cardiovascular diseases via multiple signal transduction pathways, such as Wnt/β-catenin ( Guo et al, 2012 ), TGF-β1-SMAD-3 ( Jope et al, 2007 ; Lal et al, 2014 ) and apoptosis ( Lal et al, 2015 ; Su et al, 2019 ).…”